Physostigmine antagonizes ketamine-induced noradrenaline release from the medial prefrontal cortex in rats

Brain Research

Volumn 840, Issue 1-2, 1999, Pages 175-178

  Kubota, Takeshi ^a   Hirota, Kazuyoshi ^a   Anzawa, Noriyuki ^a   Yoshida, Hitoshi ^a   Kushikata, Tetsuya ^a   Matsuki, Akitomo ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Ketamine; Medial prefrontal cortex; Noradrenaline; Physostigmine; Rat

Indexed keywords

ANESTHETIC AGENT; CHOLINESTERASE INHIBITOR; KETAMINE; NORADRENALIN; PHYSOSTIGMINE;

ANESTHESIA MECHANISM; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; MICRODIALYSIS; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANESTHESIA; ANESTHETICS, DISSOCIATIVE; ANIMALS; CHOLINESTERASE INHIBITORS; KETAMINE; MALE; NOREPINEPHRINE; PHYSOSTIGMINE; PREFRONTAL CORTEX; RATS; RATS, WISTAR; TIME FACTORS;

EID: 0033523490     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01793-X     Document Type: Article

References (29)

1. Balmer H.G.R., Wyte S.R. Antagonism of ketamine by physostigmine. Br. J. Anaesth. 49:1979;510.
2. Beani L., Tanganelli S., Antonelli T., Bianchi C. Noradrenergic modulation of cortical acetylcholine release is both direct and γ-aminobutyric acid-mediated. J. Pharmacol. Exp. Ther. 236:1986;230-236.
3. Bunney B.S., Aghajanian G.K. Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques. Life Sci. 19:1976;1783-1789.
4. Corssen G., Domino E.F. Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth. Analg. 45:1966;29-40.
5. Cuadra G., Summers K., Giacobini E. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmocol. Exp. Ther. 270:1994;277-284.
6. Drummond J.C., Brebner J., Galloon S., Young P.S. A randomized evaluation of the reversal of ketamine by physostigmine. Can. Anaesth. Soc. J. 26:1979;288-295.
7. 2-muscarinic receptors to excite rat locus coelureus neurons. Br. J. Pharmacol. 85:1985;733-735.
8. Figallo E.M., Wingard L.B. Jr. Effects of physostigmine, scopolamine, and mecamylamine on the sleeping time induced by ketamine in the rat. Psychopharmacology. 61:1979;59-62.
9. Griffiths R., Norman R.I. Effects of anaesthetics on uptake, synthesis and release of transmitters. Br. J. Anaesth. 71:1993;96-107.
10. Hirota K., Lambert D.G. Ketamine: its mechanism(s) of action and unusual clinical uses. Br. J. Anaesth. 77:1996;441-444.
11. T. Kubota, N. Anzawa, K. Hirota, H. Yoshida, T. Kushikata, A. Matsuki, Effects of ketamine and pentobarbital on noradrenaline release from the medial prefrontal cortex in rats, Can. J. Anaesth. (1999) in press.
12. Lawrence D., Livingston A. The effect of physostigmine and neostigmine on ketamine anaesthesia and analgesia. Br. J. Pharmacol. 67:1979;426P.
13. Livingston A., Waterman A. The effects of cholinergic and anticholinergic drugs on ketamine anaesthesia in rats. J. Physiol. 277:1978;56P.
14. Mallick B.N., Alam M.N. Different types of norepinephrinergic receptors are involved in preoptic area mediated independent modulation of sleep-wakefulness and body temperature. Brain Res. 591:1992;8-19.
15. Manshardt J., Wurtman R.J. Daily rhythm in the noradrenaline content of rat hypothalamus. Nature. 217:1968;574-575.
16. Mimura M., Namiki A., Kishi R., Ikeda T., Miyake H. Antagonistic effect of physostigmine on ketamine-induced anesthesia. Psychopharmacology. 102:1990;399-403.
17. Mimura M., Namiki A., Kishi R., Ikeda T., Miyake H., Iwasaki H. Central cholinergic action produces antagonism to ketamine anesthesia. Acta Anaesthesiol. Scand. 36:1992;460-462.
18. Mohan Kumar V., Datta S., Chhina G.S., Gandhi N., Singh B. Sleep-awake responses elicited from medial preoptic area on application of norepinephrine and phenoxybenzamine in free moving rats. Brain Res. 322:1984;322-325.
19. Morilak D.A., Fornal C.A., Jacobs B.L. Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats: II. Cardiovascular challenge. Brain Res. 422:1987;24-31.
20. Nakane H., Shimizu N., Hori T. Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis. Am. J. Physiol. 267:1994;R1559-R1566.
21. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, San Diego, USA, 1986.
22. Richards C.D. Actions of general anaesthetics on synaptic transmission in the CNS. Br. J. Anaesth. 55:1983;201-207.
23. Robbins T.W. Cortical noradrenaline, attention and arousal. Psychol. Med. 14:1984;13-21.
24. Roizen M.F., White P.F., Eger E.I. II, Brownstein M. Effects of ablation of serotonin or norepinephrine brain-stem areas on halothane and cyclopropane MACs in rats. Anesthesiology. 49:1978;252-255.
25. Sara S.J. Noradrenergic modulation of selective attention: its role in memory retrieval. Ann. N. Y. Acad. Sci. 444:1985;178-193.
26. Sussman D.R. A comparative evaluation of ketamine anesthesia in children and adults. Anesthesiology. 40:1974;459-464.
27. Toro-Matos A., Rendon-Platas A.M., Avila-Valdez E., Villarreal-Guzman R.A. Physostigmine antagonizes ketamine. Anesth. Analg. 59:1980;764-767.
28. Van Gaalen M., Kawahara H., Kawahara Y., Westerink B.H.C. The locus coeruleus noradrenergic system in the rat brain studied by dual-probe microdialysis. Brain Res. 763:1997;56-62.
29. Yokoo H., Tanaka M., Yoshida M., Tsuda A., Tanaka T., Mizoguchi K. Direct evidence of conditioned fear-elicited enhancement of noradrenaline release in the rat hypothalamus assessed by intracranial microdialysis. Brain Res. 536:1990;305-308.